Our study takes into consideration the significance of increased miRNA21, miRNA126, and miRNA146, as well as MMP1 and MMP9, that may be considered as potential candidate biomarkers for the early diagnosis of acute myocardial infarction and also for the left ventricular systolic dysfunction as well as plaque vulnerability. This evidence concerns the gene MMP9 and acute myocardial infarction.